Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.
Press releases published on June 12, 2025
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
GlobeNewswire
·
June 12, 2025
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …
New Wave Announces Proposed Name Change and Reiterates Its Investment Policy
GlobeNewswire
·
June 12, 2025
Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it is proposing a name change and reiterates its Investment Policy and strategic focus. …
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
GlobeNewswire
·
June 12, 2025
CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received the remaining $10 million in …
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
GlobeNewswire
·
June 12, 2025
PRINCETON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced new preclinical data on the use of Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel) in a mouse …
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire
·
June 12, 2025
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study results expanded upon top line data …
Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström…
GlobeNewswire
·
June 12, 2025
Complete response achieved in CLL; overall objective response rate of 80.9% in CLL patients and 84.2% in patients with WM Bexobrutideg was well tolerated with no new safety signals observed with longer duration on study or higher doses Data reinforces …
Rumble Names Ben Torres Ezrick, Former Marketing Leader with Zoom and Google, as First-Ever CMO
GlobeNewswire
·
June 12, 2025
LONGBOAT KEY, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today named its first-ever Chief Marketing Officer, Ben Torres Ezrick, a marketing leader with a career spanning the tech, …
Nuveen Selects Molecule Software’s ETRM to Scale Renewable Trading Capabilities
GlobeNewswire
·
June 12, 2025
HOUSTON, June 12, 2025 (GLOBE NEWSWIRE) -- Molecule Software is today announcing that global investment leader Nuveen, a TIAA company, has selected Molecule’s future-ready ETRM software to accelerate its expanding renewable power trading operations. Nuveen …
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
GlobeNewswire
·
June 12, 2025
EXTON, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the publication of pivotal clinical trial results in the American …
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
GlobeNewswire
·
June 12, 2025
– 26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population – – Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy- …
I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
June 12, 2025
ROCKVILLE, Md., June 12, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (“I-Mab” or the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that on …
Gen-Z Founder Launches Nebula — The AI Tool for the 32,000 AI Tools
GlobeNewswire
·
June 12, 2025
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- With over 400 million people using artificial intelligence tools daily, the market for AI-driven solutions has grown rapidly — now boasting over 32,000 tools worldwide. Yet, despite this exponential growth, …
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
GlobeNewswire
·
June 12, 2025
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy Acquisition of CureVac will complement …
BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
GlobeNewswire
·
June 12, 2025
Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer wichtiger Meilenstein in der Umsetzung von BioNTechs Onkologie-Strategie Die Übernahme …
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewswire
·
June 12, 2025
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central …
The Eclipse Foundation Launches the S-CORE Project: The Automotive Industry's First Open Source Core Stack for Software-Defined Vehicles
GlobeNewswire
·
June 12, 2025
BRUSSELS, June 12, 2025 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced the upcoming 0.5 release of the Safety Open Vehicle Core (S-CORE) project, the first open source core software …
Eviden launches its XMC Ethernet switch card, a cybersecure and sovereign solution for critical environments
GlobeNewswire
·
June 12, 2025
Press Release Eviden launches its XMC Ethernet switch card, a cybersecure and sovereign solution for critical environments Paris, France – June 12, 2025 – Eviden, the Atos Group product brand leading in advanced computing, cybersecurity products, mission- …
Eviden lance sa carte switch Ethernet XMC, une solution cyber sécurisée et souveraine pour environnements critiques
GlobeNewswire
·
June 12, 2025
Communiqué de presse Eviden lance sa carte switch Ethernet XMC, une solution cyber sécurisée et souveraine pour environnements critiques Paris, France – 12 juin 2025 – Eviden, la branche produit du Groupe Atos leader dans le calcul avancé, les produits de …
Multiverse Computing Raises $215M to Scale Ground-Breaking Technology that Compresses LLMs by up to 95%
GlobeNewswire
·
June 12, 2025
SAN SEBASTIAN, Spain , June 12, 2025 (GLOBE NEWSWIRE) -- Multiverse Computing, the global leader in quantum-inspired AI model compression, has developed CompactifAI, a compression technology capable of reducing the size of LLMs (Large Language Models) by …
XRP News: Xpfinance Presale Fills 41% In Token Allocation, Set To Launch Demo On XRP Testnet
GlobeNewswire
·
June 12, 2025
VILNIUS, Lithuania, June 12, 2025 (GLOBE NEWSWIRE) -- Xpfinance, a lending …